Abstract-The aim of the present study was to evaluate the influence of the chitosan chain length on the drug loading and releasing in VFS (vaginal fluid simulant). Thiolated chitosan nanoparticles (TCS-NPs) were prepared using thioglycolic acid and 1-ethyl-3-3-(3-dimethylaminopropyl)carbodimide hydrochloride (EDC) and characterized with FTIR. The degree of thiol substitution was found out by Ellman's method. TCS-NPs were developed using ionic cross-linking reaction with pentasodiumtripolyphosphate (TPP). Curcumin (CUR) loaded nanoparticles were obtained by encapsulation. DLS and SEM characterized these NPs with diameter between 200 ± 50 nm. Zeta potential of NPs was 11-38 mv. The maximal encapsulation efficiency was 86.26%. The in vitro drug release studies in VFA at pH 4.2 showed a sustained release profile over a period of 3 days.
INTRODUCTION
Due to dissatisfaction and their disadvantages, previous drug delivery methods are progressively abandoned in favor of novel pharmaceutical formulations. In particular, among the non-invasive administration routes, the mucosal routes, such as nasal, pulmonary, oral and vaginal routes, are attracting a great deal of interest, owing to their feasibility for local delivery to target tissues and delivery of the active pharmaceutical ingredient (API) to the circulatory system [1] .
Among the various mucosal routes of drug delivery, the vaginal route offers many advantages such as its large permeation area, rich vascularization, by passing the first-pass metabolism and relatively low enzymatic activity. Several studies have shown that the vaginal cavity is an effective route for drug administration intended mainly for local action. Vaginal drug delivery specifically refers to the delivery of drugs within or through the vaginal mucosa for local or systemic pharmacological action [2] . Currently, there are a variety of pharmaceutical products available on the market designed for intravaginal therapy (tablets, creams, suppositories, pessaries, foams, solutions, ointments and gels). However, their efficacy is often limited by a poor retention at the site of action due to the selfcleaning action of the vaginal tract [3] . Rapid clearance from the site of drug action is an important factor limiting the efficacy of drugs administered to these parts, either for mechanisms that often lead to a poor bioavailability of applied drugs [4] .
Mucoadhesion can be defined as the ability of synthetic or biological macromolecules to adhere to mucosal tissues [5] . Mucoadhesive drug delivery systems promise several advantages that raise uptake, leading to an increase in the bioavailability of the drug and reduction in the frequency of dosing which results to improving patient compliance. A wide range of materials, such as natural and synthetic polymers, lipids, and surfactants, has been employed to prepare drug-containing nanocarriers [6] . Among the materials proposed for mucosal delivery, polysaccharides have gained attention because of their outstanding physical and biological properties. In particular, cationic polymers such as chitosan and its derivatives generate particular interest [1, 7] .
The biopolymer chitosan is obtained by alkaline deacetylation of chitin, which is one of the most abundant polysaccharides in nature. Recently, much attention has been paid to chitosan because of its favorable biological properties such as biodegradability, biocompatibility and non-toxicity as well as its physicochemical properties. Chitosan has been used as an absorption enhancer, drug carrier, mucoadhesive and permeation-enhancing polymer in formulations for 1 The article is published in the original.
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POLYMER SCIENCE, SERIES A Vol. 59 No. 6 2017 DEVELOPMENT OF THIOLATED CHITOSAN NANOPARTICLES 859 buccal/sublingual, nasal, gastrointestinal, vaginal, colonic drug delivery and for gene delivery. The amino groups on the chitosan backbone provide benefit for scientists to modify chitosan in order to gain certain additional advantageous properties. A further modification of chitosan is based on the immobilization of thiol groups leading to so-called "thiolatedchitosans" [8] . Thiolatedchitosans (TCS) show various promising properties in the field of pharmaceutical technology such as mucoadhesion, efflux pumps inhibition and permeation enhancement [9] . The strong cohesive properties of thiolatedchitosans make them highly suitable excipients for controlled drug release dosage forms [10] . Moreover, solutions of thiolatedchitosans display in situ gelling properties at physiological pH values. In situ gelling properties of thiolated chitosan were significantly improved in comparison to unmodified chitosan. The improvement is based on the formation of inter-and/or intramolecular disulfide bonds under physiological pH [6, 9, 11] . Curcumin (CUR), the major yellow pigment found in turmeric, has been significantly studied. It has been widely used in health care such as in skin, pulmonary, GIT (Gastric Intestinal Tube) and liver disorders, aches, wounds, sprains; for preservation of food and as a yellow dye for textiles. Curcumin has been shown to possess antioxidant, anti-inflammatory, antibacterial, and anticancer activities. However, curcumin has a very low oral bioavailability due to its poor absorption in the GIT, rapid metabolism by the liver and elimination in the faces. It has been reported that even after oral ingestion of 8 g curcumin, only 0.5-2.0 μM of curcumin peak levels were detected in the blood plasma of patients [12] . One of limiting factor of curcumin is that it's extremely sensitive at physiological pH. A simple way of solving the limiting factors of curcumin is to improve its bioavailability, protect it from degradation and metabolism. Various types of nanoparticles (NPs), such as polymer NPs, polymeric micelles, liposome/phospholipid, nano-/microemulsions, nanogels, solid lipid NPs were used for that [13] . The use of mucoadhesive polymer as a new approach to improve the efficacy of drug delivery systems was first developed in the early 1980s, and had since then been exploited in ocular, nasal, vaginal and buccal drug delivery systems [12] .
The nanoformulations of CUR and 5-fluroouracil (5-FU) were developed in TCS [14] . Anitha et al. showed the combination of 5-FU-TCSNPs and CUR-TCSNPs enhanced anticancer effects on colon cancer cells in vitro and improved the bioavailability of the drugs in vivo [13] . The developed NPs were about 150 ± 50 nm in size with colloidal stability and blood compatibility. Biophysical properties of tenofovirloaded thiolated chitosan nanoparticles were evaluated for HIV prevention [15] . Meng et al. reported that anti-HIV microbicid TFV-loaded TCSNPs can be highly mucoadhesive and noncytotoxic vaginal drug delivery system [14] . The mean diameter of the optimal NP formulations ranges from 240 to 252 nm, with a maximal encapsulation efficiency of 22.6%.
The aim of the present study was to evaluate the influence of the chitosan chain length on the loading and releasing drug in VFS (vaginal fluid stimuli). Thiolated chitosan were prepared using thioglycolic acid and 1-ethyl-3-3-(3-dimethylaminopropyl)carbodimide hydrochloride (EDC). TCS-NPs were developed using ionic cross-linking reaction with pentasodiumtripolyphosphate (TPP). Curcumin (CUR) loaded nanoparticles (CUR-TCS-NPs) were obtained by encapsulation. The CUR-TCS-NPs were developed with curcumin of different molecular weight (150, 400, and 600 KDa) and then drug loading and releasing properties were studied using spectrophotometry. EXPERIMENTAL Chitosan (molecular weight 1.506 × 10 5 kDa and degree of deacetylation 80%) was purchased from Sigma Japan. CS with 400 kDa was purchased from Chitotech, TPP, dialysis tubings (molecular weight cut-off 12 kDa), EDC, TGA (thio glycolic acid), Ellman's reagent, curcumin, acetic acid, sodium chloride, potassium hydroxide, calcium hydroxide, albumin, urea, glucose was purchased from Sigma Aldrich and hydrochloric acid, lactic acid, glycerol, acetic acid were purchased from Merck.
For synthesis of thiolated chitosan, 500 mg of chitosan (with different molecular mass) was dissolved in 50 mL of 1% acetic acid. Thereafter, EDC was added in a final concentration of 125 mM in order to activate the carboxylic acid moieties of the subsequently added TGA (in 1 mL demineralized water) (Scheme 1). After proper mixing of these two, 500 mg TGA was added and the pH of the medium was adjusted to 5. To avoid the formation of disulfide bonds between the polymer chains by oxidation during the coupling reaction, the synthesis was performed at pH 5.0. At that pH, the amount of the reactive form for the oxidation of thiol groups (thiolate anions) is low and the formation of disulfide bonds can be minimized. Then the reaction mixture was incubated for 3-4 h in dark at room temperature under constant stirring. In order to eliminate the TCS from the reaction mixture, the polymer solutions were dialyzed in tubings of cellulose membrane with a molecular weight cut-off of 12 kDa for 3 days in dark against 5 mM HCl, then two times against the same medium but containing 1% NaCl to reduce the ionic interactions between the cationic polymer and the anionic sulfhydryl compound. To maintain the pH of the medium at 4, the samples were again dialyzed against 5 mM HCl for 2 days. Control samples were made in the same way without adding TGA. During dialysis, the sample containers were kept in dark at 4°C for avoiding the oxidation of sulfhydryl groups. After dialysis, drying the frozen aqueous polymer lyophilized the samples and controls; the lyophilized product was used for further studies [16] .
